Amphastar Pharmaceuticals (AMPH) Gross Profit Growth (5y) (2018 - 2026)
Powered by 
Analysis
Amphastar Pharmaceuticals (AMPH) Gross Profit Growth (5y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.72 Bn | 39.07 Bn | 2.15 Bn |
| 2 | Viatris | 19.14 Bn | 18.26 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.89 Bn | 9.71 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.46 Bn | 5.34 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.33 Bn | 494.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 994.43 Mn | 704.31 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 399.34 Mn | 358.09 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.33 Mn | 178.33 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.56% |
| Mar 31, 2026 | 9.37% |
| Dec 31, 2025 | 18.39% |
| Sep 30, 2025 | 21.99% |
| Jun 30, 2025 | 21.12% |
| Mar 31, 2025 | 18.28% |
| Dec 31, 2024 | 21.02% |
| Sep 30, 2024 | 23.66% |
| Jun 30, 2024 | 24.06% |
| Mar 31, 2024 | 23.86% |
| Dec 31, 2023 | 22.61% |
| Sep 30, 2023 | 29.94% |
| Jun 30, 2023 | 22.78% |
| Mar 31, 2023 | 34.19% |
| Dec 31, 2022 | 28.28% |
| Sep 30, 2022 | 23.27% |
| Jun 30, 2022 | 18.90% |
| Mar 31, 2022 | 19.61% |
| Dec 31, 2021 | 23.02% |
| Sep 30, 2021 | 13.14% |